SaniSure, a global developer and manufacturer of single-use technology for the biopharmaceutical industry, announced today it has acquired GL Engineering (GLE) of East Hanover, New Jersey.

SaniSure, a global developer and manufacturer of single-use technology for the biopharmaceutical industry, announced today it has acquired GL Engineering (GLE) of East Hanover, New Jersey.
AllCells, the industry leader in the procurement and customization of human-derived hematological tissues and services, is pleased to announce the expansion of its flagship processing facility in Alameda, California.
Amcor Unveils State-of-the-art Healthcare Packaging Facility In Singapore To Serve Accelerating Customer Demands In Asia Pacific
Grand River Aseptic Manufacturing (“GRAM”), an agile and modern parenteral contract development and manufacturing organization (CDMO), completed its major $60 million expansion project and recently took occupancy.
In line with the increased focus on the medical market segment, Coveris is taking a gigantic leap forward to modernize their medical packaging production facilities. With an extensive EUR 10 m investment program, Coveris strives to become best in class when it comes to process transparency, cleanliness and quality.
Sexton Biotechnologies has announced a new collaboration with BioSpherix Medical. As a tool and technologies partners of the Cell and Gene industry, Sexton and BioSpherix both recognize the need for cost-effective and flexible automation solutions during cell and gene therapy process development. While some upstream bioprocesses have been successfully automated, the final steps of downstream bioprocess, namely Fill-Finish, are often done manually with associated risks of contamination and user error.
Integrity Cleanroom is pleased to announce that it has begun commercial transactions with a brand new ecommerce platform and a dedicated team of professionals based in Texas.
Together these five companies have put together complex build solutions in response to the coronavirus. Individually they were the best for being the fastest of their building type, together they provide the complete solution within weeks, regardless of the requirements. RPM acts as the quarterback pulling in a team of top North American manufacturers with the specific purpose of delivering rapid deployment Community Response Facilities (CRF) that are designed to meet each community’s critical needs. If the location requires conversion of an existing structure, a large building shell that goes up quickly, or mobile secure steel buildings, together we have it covered.
Germfree delivered a 53-foot biocontainment cleanroom trailer to a major US pharmaceutical company where they will work on a COVID-19 vaccine. This is the first, of what is expected to be, many mobile laboratory spaces that will be delivered to scientists and organizations working on virus and antibody testing, vaccine development, research, and deployment solutions.
3M and Ford are collaborating on specific ways the companies can rapidly combine complementary capabilities and resources to help meet a surge in demand for personal protective equipment due to the COVID-19 outbreak.
Hygiene expert Christeyns expands its activities in the Life Science Division with the acquisition of Pliwa, German producer of disinfection products for hospitals and dental care. Although negotiated and signed before the corona crisis, the transaction – which was closed last Friday – will allow Christeyns to increase its production capacity of disinfectants for medical applications. As such the company hopes to provide even better support to the medical sector in these challenging times.
Medivant Health is currently building a 33,000-square-foot generic drug manufacturing facility in Chandler, Arizona. The first phase will create 10,000 square feet of manufacturing and laboratory space able to produce 40,000 vials of generic drug products every day. Medivant is a new Current Good Manufacturing Practice (CGMP) Manufacturer. Medivant is unique in that its sole purpose is to fill this generic drug shortage void. The facility is fully automated with minimal human intervention.